Last Updated on March 12, 2025
By embracing digital transformation and innovative technologies, we are enhancing our regulatory capabilities, streamlining processes, and reducing processing timelines to facilitate the ease of doing business.
Dr. Obaidullah
The Drug Regulatory Authority of Pakistan (DRAP) is mandated to regulate therapeutic goods. It is our unwavering commitment to strengthen the regulatory framework and make it more efficient in order to ensure access to safe, quality, and effective therapeutic goods for the people of Pakistan and beyond.
DRAP’s commitment to regulatory compliance is steadfast and driven by the need to prioritize public health while fostering a business-friendly environment for the Therapeutic Goods manufacturing industries. To align Pakistan’s therapeutic goods ecosystem with international best regulatory practices and compliance standards, DRAP aims at international accreditations, particularly WHO Global benchmarking tool for National Regulatory Authorities (NRAs).
We have zero tolerance policy for substandard and falsified products, safeguarding the integrity of the entire supply chain and are committed to ensure integrity of the entire supply chain by embracing transformation and adopting technology which is instrumental in enhancing our regulatory capabilities in collaboration with all stakeholders. By embracing digital transformation and innovative technologies, we are enhancing our regulatory capabilities, streamlining processes, and reducing processing timelines to facilitate the ease of doing business.
Through transparency, accountability, and good governance, DRAP is ensuring that its policies and decisions are fair, predictable, and facilitative for businesses while prioritizing public health. By adopting innovative solutions, it is aimed to improve efficiency, foster innovation, promote research and development, and ensure timely access to essential therapeutic goods. Our focus on ease of doing business reflects our commitment to a progressive regulatory environment that encourages local and international investment in Pakistan’s healthcare sector.
I earnestly urge all stakeholders—encompassing provincial health departments, healthcare professionals, industry partners, and international collaborators—to unite with us on this pivotal journey. Your unwavering support and collaborative efforts are indispensable in ensuring equitable access to quality healthcare for all, while fostering a regulatory environment that champions innovation, adherence to standards, and sustainable progress.